Atlas Trials

Safety and Efficacy of MMX Mesalamine/Mesalazine in Pediatric Subjects With Mild to Moderate Ulcerative Colitis

Clinical trial NCT02093663 · COMPLETED

Trial details

NCT number
NCT02093663
Sponsor
Shire
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Ulcerative Colitis
Start date
2014-12-12
Primary completion
2018-11-28
Enrollment
107

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.